BE794333A - NITROGEN THERAPEUTIC HETEROCYCLIC COMPOUNDS - Google Patents

NITROGEN THERAPEUTIC HETEROCYCLIC COMPOUNDS

Info

Publication number
BE794333A
BE794333A BE794333DA BE794333A BE 794333 A BE794333 A BE 794333A BE 794333D A BE794333D A BE 794333DA BE 794333 A BE794333 A BE 794333A
Authority
BE
Belgium
Prior art keywords
heterocyclic compounds
nitrogen
therapeutic heterocyclic
nitrogen therapeutic
compounds
Prior art date
Application number
Other languages
French (fr)
Original Assignee
Wyeth John & Brother Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Publication date
Publication of BE794333A publication Critical patent/BE794333A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4
BE794333D 1972-01-20 NITROGEN THERAPEUTIC HETEROCYCLIC COMPOUNDS BE794333A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB272072A GB1404003A (en) 1972-01-20 1972-01-20 N-substituted-4-amidopiperidines tetrahydropyridines and pyridines

Publications (1)

Publication Number Publication Date
BE794333A true BE794333A (en) 1973-07-19

Family

ID=9744619

Family Applications (1)

Application Number Title Priority Date Filing Date
BE794333D BE794333A (en) 1972-01-20 NITROGEN THERAPEUTIC HETEROCYCLIC COMPOUNDS

Country Status (8)

Country Link
JP (1) JPS59507B2 (en)
BE (1) BE794333A (en)
CA (1) CA984843A (en)
CH (2) CH590840A5 (en)
DE (1) DE2302717A1 (en)
FR (1) FR2181678B1 (en)
GB (1) GB1404003A (en)
NL (1) NL180749C (en)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1542137A (en) * 1976-03-12 1979-03-14 Wyeth John & Brother Ltd Process for preparing 3(piperidinoalkyl)indoles
US4146630A (en) * 1976-11-12 1979-03-27 Boehringer Mannheim Gmbh Blood pressure lowering and adrenergic β-receptor inhibiting 3-(4-phenoxymethylpiperidino)-propyl-phenyl ethers
GB1582239A (en) 1976-12-11 1981-01-07 Wyeth John & Brother Ltd Piperidin-4-yl ureas and thioureas
JPS54160371A (en) * 1978-06-02 1979-12-19 Kyowa Hakko Kogyo Co Ltd Novel piperidine derivative and hypotensive agents comprising it
US4246268A (en) * 1979-02-09 1981-01-20 Richardson-Merrell Inc. Neuroleptic-4-(naphthylmethyl)piperidine derivatives
US4329348A (en) 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
US4242347A (en) 1979-06-18 1980-12-30 Ciba-Geigy Corporation Hypotensive indolylalkylpiperidyl guanidines and isoureas
EP0025111B1 (en) * 1979-08-10 1984-07-25 Sandoz Ag 3-aminopropoxyaryl derivatives, their preparation and pharmaceutical compositions containing them
US4432984A (en) * 1980-03-27 1984-02-21 Emile Bouchara Anti-hypertensive benzodioxan derivatives
US4410528A (en) * 1980-05-16 1983-10-18 Kyowa Hakko Kogyo Co., Ltd. Hypotensive piperidine derivatives
DE3025385A1 (en) * 1980-07-04 1982-01-28 Boehringer Mannheim Gmbh, 6800 Mannheim NEW TRICYCLIC ARYL ETHERS, METHOD FOR THE PRODUCTION THEREOF AND MEDICINAL PRODUCTS CONTAINING THESE COMPOUNDS
DE3200304A1 (en) * 1981-01-16 1982-08-26 Sandoz-Patent-GmbH, 7850 Lörrach 3-AMINOPROPOXYARYL DERIVATIVES, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THEM
US4359468A (en) * 1981-02-25 1982-11-16 Boehringer Ingelheim Ltd. Antiallergic N-[4-(indolyl)-piperidino-alkyl]-benzimidazolones
IL151164A0 (en) 2000-03-06 2003-04-10 Acadia Pharm Inc Azacyclic compounds for use in the treatment of serotonin related diseases
KR20100008799A (en) 2001-12-28 2010-01-26 아카디아 파마슈티칼스 인코포레이티드 Spiroazacyclic compounds as monoamine receptor modulators
MXPA04012893A (en) 2002-06-24 2005-03-31 Acadia Pharm Inc N-substituted piperidine derivatives as serotonin receptor agents.
US7253186B2 (en) 2002-06-24 2007-08-07 Carl-Magnus Andersson N-substituted piperidine derivatives as serotonin receptor agents
US7538222B2 (en) 2002-06-24 2009-05-26 Acadia Pharmaceuticals, Inc. N-substituted piperidine derivatives as serotonin receptor agents
SI2009000T1 (en) 2003-01-16 2011-09-30 Acadia Pharm Inc Selective serotonin 2A/2C receptor inverse agonists as therapeutics for neurodegenerative diseases
US7820695B2 (en) 2004-05-21 2010-10-26 Acadia Pharmaceuticals, Inc. Selective serotonin receptor inverse agonists as therapeutics for disease
US20050261278A1 (en) 2004-05-21 2005-11-24 Weiner David M Selective serotonin receptor inverse agonists as therapeutics for disease
US7790899B2 (en) 2004-09-27 2010-09-07 Acadia Pharmaceuticals, Inc. Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
AU2005289444B2 (en) 2004-09-27 2012-06-14 Acadia Pharmaceuticals Inc. Synthesis of N-(4-fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and crystalline forms
ES2423485T3 (en) 2007-03-19 2013-09-20 Acadia Pharmaceuticals Inc. Associations of 5-HT2A inverse agonists and antagonists with antipsychotics
WO2017015272A1 (en) 2015-07-20 2017-01-26 Acadia Pharmaceuticals Inc. Methods for preparing n-(4-fluorobenzyl)-n-(1-methylpiperidin-4-yl)-n'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and its tartrate salt and polymorphic form c
US10953000B2 (en) 2016-03-25 2021-03-23 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome P450 modulators
WO2017165635A1 (en) 2016-03-25 2017-09-28 Acadia Pharmaceuticals Inc. Combination of pimavanserin and cytochrome p450 modulators
US11464768B2 (en) 2016-12-20 2022-10-11 Acadia Pharmaceuticals Inc. Pimavanserin alone or in combination for use in the treatment of Alzheimer's disease psychosis
EP3615028A1 (en) 2017-04-28 2020-03-04 Acadia Pharmaceuticals Inc. Pimavanserin for treating impulse control disorder
WO2019046167A1 (en) 2017-08-30 2019-03-07 Acadia Pharmaceuticals Inc. Formulations of pimavanserin

Also Published As

Publication number Publication date
GB1404003A (en) 1975-08-28
CA984843A (en) 1976-03-02
CH590840A5 (en) 1977-08-31
NL180749C (en) 1987-04-16
NL180749B (en) 1986-11-17
CH595347A5 (en) 1978-02-15
FR2181678A1 (en) 1973-12-07
JPS4880569A (en) 1973-10-29
DE2302717A1 (en) 1973-07-26
FR2181678B1 (en) 1976-09-03
JPS59507B2 (en) 1984-01-07
NL7300838A (en) 1973-07-24

Similar Documents

Publication Publication Date Title
BE794333A (en) NITROGEN THERAPEUTIC HETEROCYCLIC COMPOUNDS
SG28676G (en) Heterocyclic n-cyanoguanidines
FI54994C (en) ENGAONGSBLOEJA MED TEJPFAESTNING
BE791025A (en) HETEROCYCLIC COMPOUNDS
IT981605B (en) PERFECTED MEMORY
IT989320B (en) PERFECTED MEMORY
BE773200A (en) HETEROCYCLIC COMPOUNDS
FI55755B (en) FOERFARANDE FOER FRAMSTAELLNING AV EN KOAGULERAD MJOELKPRODUKT MED ULTRAFILTRERING
FI55417C (en) MINNESANORDNING MED RESERVMINNESELEMENT
AU5440173A (en) Heterocyclic compounds
SE395459B (en) N-SUBSTITUTED BETA-AMINOETHYLSILANES
FI54500C (en) ICKE-ELEKTRISK BELAEGGNING MED KOPPAR
FR2333498A2 (en) NITROGEN COMPOUNDS
FI56910B (en) ANSLUTNINGSLIST MED OEVERSPAENNINGSSKYDDSANORDNING
SE7607357L (en) N- (DIETYLAMINOETHYL) -2-METHOXY-4-AMINO-5-CHLOROBENZAMIDE
BE771832A (en) HETEROCYCLIC COMPOUNDS
BE771911A (en) HETEROCYCLIC COMPOUNDS
BE802020A (en) OXIMINOMETHYL COMPOUNDS
BE794075A (en) PENICILLINS
BE809037A (en) HETEROCYCLIC COMPOUNDS
FI56555B (en) SAETT ATT LEGERA STAOL MED VANADIN
BE784132A (en) ANTHRAQUINONIC COMPOUNDS
BE777738A (en) HETEROCYCLIC COMPOUNDS
SE7513286L (en) CATHETER
BE806871A (en) BIOLOGICALLY ACTIVE COMPOUNDS

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: JOHN WYETH & BROTHER LTD

Effective date: 19880131